Tien Liang BioTech Dividends and Buybacks
Dividend criteria checks 2/6
Tien Liang BioTech is a dividend paying company with a current yield of 1.34% that is well covered by earnings.
Key information
1.3%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | n/a |
| Dividend Growth | -15.7% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | NT$0.500 |
| Payout ratio | 39% |
Recent dividend and buyback updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 4127's dividend payments have been volatile in the past 10 years.
Growing Dividend: 4127's dividend payments have fallen over the past 10 years.
Dividend Yield vs Market
| Tien Liang BioTech Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (4127) | 1.3% |
| Market Bottom 25% (TW) | 1.7% |
| Market Top 25% (TW) | 4.4% |
| Industry Average (Pharmaceuticals) | 2.2% |
| Analyst forecast (4127) (up to 3 years) | n/a |
Notable Dividend: 4127's dividend (1.34%) isn’t notable compared to the bottom 25% of dividend payers in the TW market (1.71%).
High Dividend: 4127's dividend (1.34%) is low compared to the top 25% of dividend payers in the TW market (4.42%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (39.4%), 4127's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (51.4%), 4127's dividend payments are covered by cash flows.